Reaction
Adrenocorticotropic Hormone Deficiency reporting signals
As of the last recalculation, Adrenocorticotropic Hormone Deficiency appears in 861 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is IPILIMUMAB (PRR 129.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ipilimumab | 182 | 129.0 | 129.5 |
| Pembrolizumab | 337 | 126.6 | 127.0 |
| Nivolumab | 314 | 123.0 | 123.4 |
| Durvalumab | 34 | 42.0 | 42.1 |
| Atezolizumab | 61 | 40.8 | 40.9 |
| Paclitaxel (Aibumin-Bound) | 86 | 28.0 | 28.0 |
| Pemetrexed | 24 | 27.8 | 27.8 |
| Paclitaxel | 99 | 27.2 | 27.2 |
| Carboplatin | 122 | 26.9 | 26.9 |
| Pemetrexed Disodium | 36 | 23.8 | 23.8 |
| Lenvatinib | 31 | 23.7 | 23.7 |
| Febuxostat Tablets 40 Mg | 8 | 19.2 | 19.2 |
| Febuxostat Tablets 80 Mg | 8 | 19.2 | 19.2 |
| Epoprostenol | 9 | 16.8 | 16.8 |
| Axitinib | 10 | 12.5 | 12.6 |
| Suvorexant | 5 | 9.4 | 9.4 |
| Encorafenib | 3 | 7.3 | 7.3 |